New insights at the interface between leprosy and immune-mediated rheumatic diseases

5Citations
Citations of this article
20Readers
Mendeley users who have this article in their library.

Abstract

Leprosy is an infectious and contagious disease of slow evolution, triggered by Mycobacterium leprae. Arthritis is its third most common manifestation, after cutaneous and peripheral nerve involvement. Since musculoskeletal symptoms may be the initial presentation of the disease, it is important for health professionals to recognize its rheumatic manifestations for early diagnosis and appropriate treatment, especially in endemic areas. In addition, cases of leprosy have increased globally, notably in patients undergoing treatment with TNF-α blockers and due to the increase in migration and travel of people from developing countries to developed countries. This review proposes to discuss the main scenarios of mimicry of different rheumatic diseases by leprosy, as well as the role of immunosuppressive drugs used in rheumatology practice in the treatment of reactional states and in the risk of developing the infection.

Cite

CITATION STYLE

APA

Cruz, V. A., Albuquerque, C. P. de, Guimarães, M. F. B. de R., Dionello, C. da F., Ribeiro, S. L. E., Souza, V. A. de, … Mota, L. M. H. da. (2023). New insights at the interface between leprosy and immune-mediated rheumatic diseases. Frontiers in Medicine. Frontiers Media SA. https://doi.org/10.3389/fmed.2023.1239775

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free